STERIS plc ( STE) - Key Metrics
STE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q2 | $16.33 | $2.20 | $2.97 | $2.19 |
| 2027Q1 | $15.29 | $2.05 | $3.76 | $2.86 |
| 2026Q4 | $16.21 | $2.25 | $3.42 | $2.50 |
| 2026Q3 | $15.22 | $1.96 | $3.03 | $2.03 |
| 2026Q2 | $14.84 | $1.95 | $2.92 | $2.05 |
STE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q2 | 31.35% | 23.86 |
| 2027Q1 | 30.68% | 25.68 |
| 2026Q4 | 28.05% | 24.68 |
| 2026Q3 | 32.11% | 32.34 |
| 2026Q2 | 32.26% | 31.72 |
STE Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2027Q2 | 1.04% | 0.33% |
| 2027Q1 | 1.36% | 0.30% |
| 2026Q4 | 1.13% | 0.29% |
| 2026Q3 | 0.80% | 0.25% |
| 2026Q2 | 0.83% | 0.25% |
STE
List: Contenders
Price: $263.96
Dividend Yield: 1.00%
Forward Dividend Yield: 1.09%
Payout Ratio: 40.28%
Dividend Per Share: 2.76 USD
Earnings Per Share: 8.40 USD
P/E Ratio: 30.51
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: Ireland
Volume: 489871
Ebitda: 149.1 millionMarket Capitalization: 24.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 22
DGR3: 10.06%
DGR5: 9.28%
DGR10: 9.60%
DGR20: 17.56%